Coronavirus: India approves AstraZeneca’s COVID-19 vaccine

Published: Updated:
Enable Read mode
100% Font Size

India has approved the COVID-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunization campaign in the world’s second most populous country.

Information and Broadcasting Minister Prakash Javadekar told reporters on Saturday the vaccine had been approved on Friday, confirming what sources close to the matter had told Reuters.

For more coronavirus news, visit our dedicated page.

It is the first COVID-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the US.

Javadekar said at least three more vaccines were waiting in line to be approved.

“India is perhaps the only country where at least four vaccines are getting ready,” he said.

“One was approved yesterday for emergency use, Serum’s COVISHIELD.” he said, referring to the fact that the shot is being made locally by the Serum Institute of India (SII).

For all the latest headlines follow our Google News channel online or via the app.

India has reported more than 10 million COVID-19 cases, though its rate of infection has come down significantly from a mid-September peak.

The country hopes to inoculate 300 million of its 1.35 billion people in the first six to eight months of 2021.

Read more:

Coronavirus: India likely to license COVID-19 vaccines in ‘next few weeks’

Coronavirus: India tests vaccine delivery system with nationwide trial

Coronavirus: India COVID-19 cases pass 10 million

Top Content Trending